Viewing Study NCT03098160


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-01-06 @ 2:48 PM
Study NCT ID: NCT03098160
Status: UNKNOWN
Last Update Posted: 2017-10-30
First Post: 2017-03-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Sponsor: Threshold Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module